Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alfacalcidol treatment in Crohn's disease
jRCTs041180126Completed
- Start
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of alfacalcidol in Crohn's disease. Primary endpoint: Endoscopic response rate at 3 months. Started Jun 2017; status: completed.
02
Drugs
alfacalcidol
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on jRCTs041180126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041180126.